Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Hormonal therapy in a patient with a delayed diagnosis of Turner's syndrome

Abstract

Background A 15-year-old girl presented to our clinic with short stature and delayed puberty. On examination her height was 139.3 cm, which is 13.2 cm below the 3rd percentile on a standard growth chart, and she had no clinical signs of puberty. A number of typical features of Turner's syndrome were found, including a short webbed neck, cubitus valgus, shield chest, multiple pigmented nevi, lymphedema, epicanthus and micrognathia.

Investigations Plasma follicle-stimulating hormone and luteinizing hormone levels were increased. A pelvic ultrasound demonstrated a small uterus, but the ovaries could not be visualized. The patient's bone age was 12–13 years. A horseshoe kidney was seen on renal ultrasound and an echocardiography revealed aortic coarctation. The 45,X karyotype confirmed the diagnosis.

Diagnosis Turner's syndrome.

Management Growth hormone therapy (1 IU/kg/week; 0.05 mg/kg/day) was started together with oxandrolone (0.05 mg/kg/day) and transdermal estrogen. The dose of estrogen was gradually increased from 12.5 µg/day to 25.0 µg/day and then to 50.0 µg/day over a period of 12 months. Growth hormone and oxandrolone were withdrawn after 1 year, when the patient's epiphyses had fused. Hormonal replacement therapy with estrogens was continued and the patient has reached stage 3 of pubertal development and a final height of 148.5 cm.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The patient's phenotype.

References

  1. Turner HH (1938) A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 23: 566–574

    Article  Google Scholar 

  2. Ullrich O (1930) Über typische Kombinationsbilder multipler Abartungen. Z Kinderheilk 49: 271–276

    Article  Google Scholar 

  3. Ferguson-Smith MA (1965) Karyotype–phenotype correlations in gonadal dysgenesis and their bearing on the pathogenesis of malformation. J Med Genet 2: 142–155

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Nielsen J and Wohlert M (1991) Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87: 81–83

    Article  CAS  PubMed  Google Scholar 

  5. Sybert VP and McCauley E (2004) Medical progress. Turner's syndrome. N Engl J Med 351: 1227–1238

    Article  CAS  PubMed  Google Scholar 

  6. Bondy CA et al. (2007) Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 92:10–25

    Article  CAS  PubMed  Google Scholar 

  7. Savendahl L and Davenport ML (2000) Delayed diagnoses of Turner's syndrome: proposed guidelines for change. J Pediatr 137: 455–459

    Article  CAS  PubMed  Google Scholar 

  8. Gawlik A et al. (2006) The influence of phenotypic expression on the age at diagnosis in Turner syndrome. Pediatr Endocrinol 5: 23–30

    Google Scholar 

  9. Gravholt CH (2004) Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 151: 657–687

    Article  CAS  PubMed  Google Scholar 

  10. Massa G et al. (2005) Trends in age at diagnosis of Turner syndrome. Arch Dis Child 90: 267–268

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Parker KL et al. (2003) Screening girls with Turner syndrome: the national cooperative growth study experience. J Pediatr 143: 133–135

    Article  PubMed  Google Scholar 

  12. Stephure DK et al. (2005) Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 90: 3360–3366

    Article  PubMed  Google Scholar 

  13. Rosenfeld RG et al. (1998) Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 132: 319–324

    Article  CAS  PubMed  Google Scholar 

  14. Chernausek SD et al. (2000) Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. J Clin Endocrinol Metab 85: 2439–2445

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Consent for the publication of Figure 1 was obtained from the patient.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ewa Malecka-Tendera.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gawlik, A., Malecka-Tendera, E. Hormonal therapy in a patient with a delayed diagnosis of Turner's syndrome. Nat Rev Endocrinol 4, 173–177 (2008). https://doi.org/10.1038/ncpendmet0747

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0747

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing